Vikas Lifecare [VIKASLIFE] vs Andrew Yule [ANDREWYU] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Vikas Lifecare wins in 8 metrics, Andrew Yule wins in 10 metrics, with 0 ties. Andrew Yule appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricVikas LifecareAndrew YuleBetter
P/E Ratio (TTM)62.0066.08Vikas Lifecare
Price-to-Book Ratio0.604.72Vikas Lifecare
Debt-to-Equity Ratio14.3931.10Vikas Lifecare
PEG Ratio1.95-0.07Andrew Yule
EV/EBITDA-21.42-14.38Vikas Lifecare
Profit Margin (TTM)-2.45%6.39%Andrew Yule
Operating Margin (TTM)-4.80%-51.98%Vikas Lifecare
Return on Equity-1.99%-0.84%Andrew Yule
Return on Assets (TTM)-1.46%-0.38%Andrew Yule
Free Cash Flow (TTM)$-2.35B$-235.61MAndrew Yule
1-Year Return-54.49%-38.79%Andrew Yule
Price-to-Sales Ratio (TTM)0.864.14Vikas Lifecare
Enterprise Value$5.08B$13.65BAndrew Yule
EV/Revenue Ratio1.064.37Vikas Lifecare
Gross Profit Margin (TTM)3.19%62.61%Andrew Yule
Revenue per Share (TTM)$2$7Andrew Yule
Earnings per Share (Diluted)$-0.08$0.40Andrew Yule
Beta (Stock Volatility)-0.830.54Vikas Lifecare
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Vikas Lifecare vs Andrew Yule Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Vikas Lifecare-0.91%-0.91%-3.54%-15.18%-19.56%-48.95%
Andrew Yule1.44%2.60%2.88%-12.93%7.84%-31.68%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Vikas Lifecare-54.49%-56.40%-64.09%-53.62%-53.62%-53.62%
Andrew Yule-38.79%35.06%118.50%10.33%-31.43%-6.59%

News Based Sentiment: Vikas Lifecare vs Andrew Yule

Vikas Lifecare

News based Sentiment: NEGATIVE

September brought a series of negative developments for Vikas Lifecare, including a declining stock price, worsening financial results in Q4, and continued operational challenges. The company's negative P/E ratio and substantial year-to-date stock decline signal significant investor concerns and a high level of risk.

View Vikas Lifecare News Sentiment Analysis

Andrew Yule

News based Sentiment: NEGATIVE

The month of October was largely negative for Andrew Yule & Company Ltd., with a declining stock price, negative analyst commentary, and concerning financial results. While there was a small price increase on October 1st, it was overshadowed by the overall downward trend and the company's ongoing profitability issues, making it a significant month for investors to reassess their positions.

View Andrew Yule News Sentiment Analysis

Performance & Financial Health Analysis: Vikas Lifecare vs Andrew Yule

MetricVIKASLIFEANDREWYU
Market Information
Market Cap i₹4.11B₹13.17B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i3,194,77094,078
90 Day Avg. Volume i3,108,039137,133
Last Close₹2.18₹26.81
52 Week Range₹2.15 - ₹5.35₹22.65 - ₹46.80
% from 52W High-59.25%-42.71%
All-Time High₹18.56 (Aug 31, 2020)₹99.70 (Jan 18, 2010)
% from All-Time High-88.25%-73.11%
Growth Metrics
Quarterly Revenue Growth0.00%0.01%
Quarterly Earnings Growth0.00%0.00%
Financial Health
Profit Margin (TTM) i-0.02%0.06%
Operating Margin (TTM) i-0.05%-0.52%
Return on Equity (TTM) i-0.02%-0.01%
Debt to Equity (MRQ) i14.3931.10
Cash & Liquidity
Book Value per Share (MRQ)₹3.67₹5.60
Cash per Share (MRQ)₹0.03₹0.79
Operating Cash Flow (TTM) i₹-2,920,476,000₹-218,291,000
Levered Free Cash Flow (TTM) i₹-106,139,000₹-28,383,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A₹0.00

Valuation & Enterprise Metrics Analysis: Vikas Lifecare vs Andrew Yule

MetricVIKASLIFEANDREWYU
Price Ratios
P/E Ratio (TTM) i62.0066.08
Forward P/E iN/AN/A
PEG Ratio i1.95-0.07
Price to Sales (TTM) i0.864.14
Price to Book (MRQ) i0.604.72
Market Capitalization
Market Capitalization i₹4.11B₹13.17B
Enterprise Value i₹5.08B₹13.65B
Enterprise Value Metrics
Enterprise to Revenue i1.064.37
Enterprise to EBITDA i-21.42-14.38
Risk & Other Metrics
Beta i-0.830.54
Book Value per Share (MRQ) i₹3.67₹5.60

Financial Statements Comparison: Vikas Lifecare vs Andrew Yule

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)VIKASLIFEANDREWYU
Revenue/Sales i₹923.84M₹554.76M
Cost of Goods Sold i₹894.38M₹207.42M
Gross Profit i₹29.46M₹347.34M
Research & Development iN/AN/A
Operating Income (EBIT) i₹-44.39M₹-291.78M
EBITDA i₹-12.41M₹320.54M
Pre-Tax Income i₹-38.73M₹255.40M
Income Tax i₹795,000₹18.63M
Net Income (Profit) i₹-39.53M₹201.40M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)VIKASLIFEANDREWYU
Cash & Equivalents i₹56.07M₹73.01M
Total Current Assets i₹2.70B₹2.43B
Total Current Liabilities i₹1.53B₹3.63B
Long-Term Debt i₹388.22M₹16.20M
Total Shareholders Equity i₹5.33B₹3.39B
Retained Earnings i₹82.78M₹2.07B
Property, Plant & Equipment i₹5.88M₹1.88B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)VIKASLIFEANDREWYU
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricVIKASLIFEANDREWYU
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i3,194,77094,078
Average Daily Volume (90 Day) i3,108,039137,133
Shares Outstanding i1.86B488.95M
Float Shares i1.62B48.28M
% Held by Insiders i0.16%0.89%
% Held by Institutions i0.00%0.00%

Dividend Analysis & Yield Comparison: Vikas Lifecare vs Andrew Yule

MetricVIKASLIFEANDREWYU
Last 12-Month Dividend iN/A₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A₹0.00
3-Year Avg Dividend Yield iN/A0.03%
3-Year Total Dividends iN/A₹0.01
Ex-Dividend DateN/AAug 24, 2023